Immunological Responses to Total Hip Arthroplasty

The use of total hip arthroplasties (THA) has been continuously rising to meet the demands of the increasingly ageing population. To date, this procedure has been highly successful in relieving pain and restoring the functionality of patients’ joints, and has significantly improved their quality of...

Full description

Bibliographic Details
Main Authors: Kenny Man, Lin-Hua Jiang, Richard Foster, Xuebin B Yang
Format: Article
Language:English
Published: MDPI AG 2017-08-01
Series:Journal of Functional Biomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4983/8/3/33
_version_ 1811306853564416000
author Kenny Man
Lin-Hua Jiang
Richard Foster
Xuebin B Yang
author_facet Kenny Man
Lin-Hua Jiang
Richard Foster
Xuebin B Yang
author_sort Kenny Man
collection DOAJ
description The use of total hip arthroplasties (THA) has been continuously rising to meet the demands of the increasingly ageing population. To date, this procedure has been highly successful in relieving pain and restoring the functionality of patients’ joints, and has significantly improved their quality of life. However, these implants are expected to eventually fail after 15–25 years in situ due to slow progressive inflammatory responses at the bone-implant interface. Such inflammatory responses are primarily mediated by immune cells such as macrophages, triggered by implant wear particles. As a result, aseptic loosening is the main cause for revision surgery over the mid and long-term and is responsible for more than 70% of hip revisions. In some patients with a metal-on-metal (MoM) implant, metallic implant wear particles can give rise to metal sensitivity. Therefore, engineering biomaterials, which are immunologically inert or support the healing process, require an in-depth understanding of the host inflammatory and wound-healing response to implanted materials. This review discusses the immunological response initiated by biomaterials extensively used in THA, ultra-high-molecular-weight polyethylene (UHMWPE), cobalt chromium (CoCr), and alumina ceramics. The biological responses of these biomaterials in bulk and particulate forms are also discussed. In conclusion, the immunological responses to bulk and particulate biomaterials vary greatly depending on the implant material types, the size of particulate and its volume, and where the response to bulk forms of differing biomaterials are relatively acute and similar, while wear particles can initiate a variety of responses such as osteolysis, metal sensitivity, and so on.
first_indexed 2024-04-13T08:52:58Z
format Article
id doaj.art-24a1de8cca1b415b8469204f2bd44982
institution Directory Open Access Journal
issn 2079-4983
language English
last_indexed 2024-04-13T08:52:58Z
publishDate 2017-08-01
publisher MDPI AG
record_format Article
series Journal of Functional Biomaterials
spelling doaj.art-24a1de8cca1b415b8469204f2bd449822022-12-22T02:53:24ZengMDPI AGJournal of Functional Biomaterials2079-49832017-08-01833310.3390/jfb8030033jfb8030033Immunological Responses to Total Hip ArthroplastyKenny Man0Lin-Hua Jiang1Richard Foster2Xuebin B Yang3Biomaterials and Tissue Engineering Group, School of Dentistry, University of Leeds, Leeds LS2 9JT, UKSchool of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UKSchool of Chemistry, University of Leeds, Leeds LS2 9JT, UKBiomaterials and Tissue Engineering Group, School of Dentistry, University of Leeds, Leeds LS2 9JT, UKThe use of total hip arthroplasties (THA) has been continuously rising to meet the demands of the increasingly ageing population. To date, this procedure has been highly successful in relieving pain and restoring the functionality of patients’ joints, and has significantly improved their quality of life. However, these implants are expected to eventually fail after 15–25 years in situ due to slow progressive inflammatory responses at the bone-implant interface. Such inflammatory responses are primarily mediated by immune cells such as macrophages, triggered by implant wear particles. As a result, aseptic loosening is the main cause for revision surgery over the mid and long-term and is responsible for more than 70% of hip revisions. In some patients with a metal-on-metal (MoM) implant, metallic implant wear particles can give rise to metal sensitivity. Therefore, engineering biomaterials, which are immunologically inert or support the healing process, require an in-depth understanding of the host inflammatory and wound-healing response to implanted materials. This review discusses the immunological response initiated by biomaterials extensively used in THA, ultra-high-molecular-weight polyethylene (UHMWPE), cobalt chromium (CoCr), and alumina ceramics. The biological responses of these biomaterials in bulk and particulate forms are also discussed. In conclusion, the immunological responses to bulk and particulate biomaterials vary greatly depending on the implant material types, the size of particulate and its volume, and where the response to bulk forms of differing biomaterials are relatively acute and similar, while wear particles can initiate a variety of responses such as osteolysis, metal sensitivity, and so on.https://www.mdpi.com/2079-4983/8/3/33total hip arthroplastyimplant materialswear particlesimmunological response
spellingShingle Kenny Man
Lin-Hua Jiang
Richard Foster
Xuebin B Yang
Immunological Responses to Total Hip Arthroplasty
Journal of Functional Biomaterials
total hip arthroplasty
implant materials
wear particles
immunological response
title Immunological Responses to Total Hip Arthroplasty
title_full Immunological Responses to Total Hip Arthroplasty
title_fullStr Immunological Responses to Total Hip Arthroplasty
title_full_unstemmed Immunological Responses to Total Hip Arthroplasty
title_short Immunological Responses to Total Hip Arthroplasty
title_sort immunological responses to total hip arthroplasty
topic total hip arthroplasty
implant materials
wear particles
immunological response
url https://www.mdpi.com/2079-4983/8/3/33
work_keys_str_mv AT kennyman immunologicalresponsestototalhiparthroplasty
AT linhuajiang immunologicalresponsestototalhiparthroplasty
AT richardfoster immunologicalresponsestototalhiparthroplasty
AT xuebinbyang immunologicalresponsestototalhiparthroplasty